Pharma Business 1920 Views FDA acceptance for Modus Therapeutics Malin Otmani November 7, 2018 The company announces that the …
1767 Views The appendix could be a starting point for Parkinson’s Malin Otmani November 7, 2018 A large research study shows …
Clinical Trials 1681 Views Positive results from ExpreS2ion Malin Otmani November 7, 2018 Swedish ExpreS2ion Biotech Holding AB …
Clinical Trials 1477 Views Bavarian Nordic initiates Phase 2 trial Malin Otmani November 7, 2018 The first patient has been …
Clinical Trials 1421 Views First patient dosed in Nordic Nanovector study Malin Otmani November 7, 2018 The company announces that the …
Clinical Trials 1558 Views Bavarian Nordic initiates new clinical trial Malin Otmani November 7, 2018 The new trial evaluates the …
Collaboration 2610 Views A new issue of Nordic Life Science magazine is out! Malin Otmani November 6, 2018 The latest issue of our …
Acquisition 2533 Views AstraZeneca sells drug rights to Covis Pharma for up to $371 million Malin Otmani November 6, 2018 The company has entered into …
Agreement 1394 Views Moberg Pharma signs new agreement Malin Otmani November 6, 2018 The Swedish company has signed …
Collaboration 2011 Views SwedenBIO announces initiatives to connect life sciences in the Nordics internationally Malin Otmani November 6, 2018 SwedenBIO, the trade association for …
Agreement 2065 Views LEO Pharma enters collaboration Malin Otmani October 31, 2018 Zymeworks and LEO Pharma have …
Pharma Business 1824 Views FDA approval for Lundbeck and Takeda Malin Otmani October 31, 2018 The two companies can once …
Clinical Trials 2152 Views Negative update on Lundbeck’s Schizophrenia trial Malin Otmani October 31, 2018 The company has announced that DAYBREAKi, …
Clinical Trials 3291 Views Headline results from Novo Nordisk’s PIONEER 8 trial Malin Otmani October 31, 2018 The company has announced results …
Clinical Trials 2516 Views Phase III results from AstraZeneca Malin Otmani October 31, 2018 The company has presented results …
Agreement 1377 Views AstraZeneca divests prescription medicine rights Malin Otmani October 31, 2018 The company has agreed to …